Company: SUNE
Filing Date: 2025-04-07
Form Type: 424B5
Source: 0001213900-25-029179
Chunk: 1

Company: SUNation Energy, Inc.
Filing Date: 2025-04-07
Form: 424B5
Chunk 1
---
,391,306 shares of common stock, and (z) Series B Warrants to purchase up to 17,391,306 shares of common stock. Warrant
Stockholder Approval was obtained at a special meeting of the shareholders on April 3, 2025.

The shares of common stock and common warrants
will be separately issued, but the shares of common stock and common warrants will be issued to purchasers in the ratio of one-to-one.
Each of the common warrants may be exercised for one share of our common stock. Each Series A Warrant will have an initial exercise price
of $1.725 per share (not to exceed 150% of the combined public offering price), which will be subject to an issuance date reset price
adjustment and also subject to adjustment upon a dilutive issuance. Each Series B Warrant will have an initial exercise price of $2.875
per share (not to exceed 250% of the combined public offering price), which will be subject to an issuance date reset price adjustment
and also subject to adjustment upon a dilutive issuance. Each Series B Warrant may also be exercised pursuant to an alternative cashless
provision in which the holder will receive three shares of common stock for each share of common stock they would have received in a cash
exercise for each Series B Warrant they exercise.

The exercise price of the common warrants will
be reset to a price equal to the following: if the lowest volume weighted average price (“VWAP”) of our common stock during
the period from five trading days immediately preceding the issue date of the Series A Warrants and Series B Warrants and ending five
trading days immediately after such issue date (the “Event Market Price”) is less than the exercise price of the Series A
Warrants or Series B Warrants, respectively, then the exercise price will be reduced to the Event Market Price and the number of shares
issuable upon exercise will be proportionately adjusted such that the aggregate price will remain unchanged, provided, however, the adjusted
exercise price shall not be less than 20% of the of the “Minimum Price” as defined under Nasdaq’s rules (the “Floor
Price”). In addition, if, while the common warrants are outstanding, we issue or sell, or are deemed to have issued or sold, any
common stock and/or common stock equivalents other than in connection with certain exempt issuances, at a purchase price per share less
than the exercise price of the common warrants in effect immediately